Latest News
What the OIG found about Medicare Part B drug payments - DHS-OIG
Medicare Part B pays for covered drugs and biologicals, including covered preventive vaccines, using several methodologies. The Average Sales Price (ASP) is the primary methodology used for Pricing Part B Drugs; however, in the absence of ASP data, CMS may use wholesale acquisition cost-based prices (WAC). Additionally, in certain circumstances CMS substitutes payment amounts with Office of the Inspector General-derived amounts based on the Widely Available Market Price (WAMP) or the Average Manufacturer’s Price (AMP). Medicare pays for preventive Part B vaccines at a rate of 95 percent of the average wholesale price (AWP).
In a recent report from the U.S. Department of Health and Human Services Office of Inspector General (OIG) found the Centers for Medicare & Medicaid Services (CMS) application of its price-substitution policy to drugs identified and referred by OIG saved Medicare and its enrollees $76 million since 2013. To read the OIG report, click here…
The link provided above connects readers to the full content of the posted article. The URL (Internet address) for this link is valid on the posted date; socialsecurityreport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or socialsecurityreport.org.